(Q54005631)

23 May 2018

title

A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm. (English)

1 reference

23 May 2018

1 reference

1 reference

2

Kassell NF

1 reference

23 May 2018

author name string

Findlay JM

1

1 reference

23 May 2018

Weir BK

3

1 reference

23 May 2018

Haley EC Jr

4

1 reference

23 May 2018

Kongable G

5

1 reference

23 May 2018

Germanson T

6

1 reference

23 May 2018

Truskowski L

7

1 reference

23 May 2018

Alves WM

8

1 reference

23 May 2018

Holness RO

9

1 reference

23 May 2018

Knuckey NW

10

1 reference

23 May 2018

language of work or name

English

0 references

publication date

1 July 1995

1 reference

23 May 2018

published in

Neurosurgery

1 reference

23 May 2018

volume

37

1 reference

23 May 2018

issue

1

1 reference

23 May 2018

page(s)

168-76; discussion 177-8

1 reference

23 May 2018

Modification of experimental post-subarachnoid hemorrhage vasculopathy with intracisternal plasmin

uses

randomized experiment

0 references

cites work

1 reference

https://api.crossref.org/works/10.1227%2F00006123-199507000-00041

Modification of experimental post-subarachnoid hemorrhage vasculopathy with intracisternal plasmin

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F00006123-199507000-00041

Intracisternal recombinant tissue plasminogen activator after aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F00006123-199507000-00041

Safety and efficacy of intrathecal thrombolytic therapy in a primate model of cerebral vasospasm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F00006123-199507000-00041

Comparison of intrathecal administration of urokinase and tissue plasminogen activator on subarachnoid clot and chronic vasospasm in a primate model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F00006123-199507000-00041

Effect of intrathecal fibrinolytic therapy on clot lysis and vasospasm in patients with aneurysmal subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F00006123-199507000-00041

Failure of intracisternal tissue plasminogen activator to prevent vasospasm in certain patients with aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F00006123-199507000-00041

Effect of early operation for ruptured aneurysms on prevention of delayed ischemic symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F00006123-199507000-00041

Vasospasm prevention with postoperative intrathecal thrombolytic therapy: a retrospective comparison of urokinase, tissue plasminogen activator, and cisternal drainage alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F00006123-199507000-00041

Phase I trial of tissue plasminogen activator for the prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F00006123-199507000-00041

10.1227/00006123-199507000-00041

21 January 2018

Identifiers

DOI

1 reference

23 May 2018

PubMed ID

8587685

1 reference

23 May 2018